Novartis India concludes transfer of its Animal Health Division to Elanco India

01 Jan 2016 Evaluate

Novartis India has completed the transaction for the transfer of its Animal Health Division to Elanco India on December 31, 2015. This is pursuant to the approval received from the Foreign Investment Promotion Board, Government of India and the Competition Commission of India.

The company had earlier entered into transaction for transfer of its Animal Health Division as a going concern by way of a slump sale to Elanco India, or another affiliate of Eli Lilly and Company.

Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.



Novartis Share Price

1052.10 -20.70 (-1.93%)
13-Nov-2024 12:47 View Price Chart
Peers
Company Name CMP
Redington 185.90
Adani Enterprises 2835.30
Amrapali Industries 18.11
Rashi Peripheral 363.45
Compuage Infocom 2.71
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.